Who
Joseph K. Belanoff
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Corcept Therapeutics.
In numbers
- Trades disclosed
- 167
- Buys
- 0
- Sells
- 76
- Bought
- $0
- Sold
- $59.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 30 Jun 2005
- Last trade
- 1 Jun 2026
- Last filed
- 2 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 2 Jun 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $895K12,837 at $69.74 | filing |
| 1 Jun 2026filed 2 Jun 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $895K12,837 at $69.74 | filing |
| 29 May 2026filed 2 Jun 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —150,000 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —150,000 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —150,000 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —150,000 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $2.0M40,000 at $50.10 | filing |
| 1 May 2026filed 5 May 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $2.0M40,000 at $50.10 | filing |
| 25 Mar 2026filed 27 Mar 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1.3M26,198 at $50.07 | filing |
| 25 Mar 2026filed 27 Mar 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1.3M26,198 at $50.07 | filing |
| 27 Feb 2026filed 3 Mar 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —460,000 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —460,000 at $0.00 | filing |
| 24 Dec 2025filed 29 Dec 2025 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —550,000 at $0.00 | filing |
| 24 Dec 2025filed 29 Dec 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $2.1M550,000 at $3.88 | filing |
| 24 Dec 2025filed 29 Dec 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $25.6M306,846 at $83.59 | filing |
| 24 Dec 2025filed 29 Dec 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —243,154 at $0.00 | filing |
| 24 Dec 2025filed 29 Dec 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code J | —243,154 at $0.00 | filing |
| 1 Dec 2025filed 3 Dec 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $3.2M40,000 at $79.77 | filing |
News
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells $93,474.00 in StockCORT · tickerreport.com · 8 Oct 2026Comparing Corcept Therapeutics (NASDAQ:CORT) & Xeris Biopharma (NASDAQ:XERS)CORT · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Joseph K. Belanoff; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.